DeGette Working On ‘Cures’ Clinical Trials Language, Says FDA Part Of Process

April 14, 2015 at 2:37 PM
Rep. Diana DeGette (D-CO) told reporters and stakeholders Tuesday (April 14) that she has been working closely with FDA on alternative clinical trials language for inclusion in the final version of the Energy and Commerce Committee's Cures bill, which she expects to be unveiled soon. FDA, along with former agency Commissioner Margaret Hamburg, have been “with us every step of the way,” she said. DeGette added that the reforms included in the final bill will need to be adequately funded...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.